$169 Million is the total value of PURA VIDA INVESTMENTS, LLC's 66 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 542.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLV | Buy | SELECT SECTOR SPDR TRput | $13,024,000 | +57.5% | 160,000 | +60.0% | 7.69% | +122.4% |
| MRK | New | MERCK & CO. INCcall | $10,894,000 | – | 200,000 | +100.0% | 6.44% | – |
| BMY | New | BRISTOL-MYERS SQUIBB COcall | $6,325,000 | – | 100,000 | +100.0% | 3.74% | – |
| CI | New | CIGNA CORPORATIONcall | $5,871,000 | – | 35,000 | +100.0% | 3.47% | – |
| MRK | New | MERCK & CO. INC | $5,447,000 | – | 100,000 | +100.0% | 3.22% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $5,016,000 | +110.8% | 45,000 | +126.1% | 2.96% | +197.5% |
| BAX | Buy | BAXTER INTL INC | $4,878,000 | +7.8% | 75,000 | +7.1% | 2.88% | +52.2% |
| SIEN | New | SIENTRA INCcall | $4,865,000 | – | 503,600 | +100.0% | 2.87% | – |
| XENT | Buy | INTERSECT ENT INC | $4,323,000 | +33.4% | 110,000 | +10.0% | 2.55% | +88.3% |
| EW | New | EDWARDS LIFESCIENCES CORP | $3,488,000 | – | 25,000 | +100.0% | 2.06% | – |
| MDT | Buy | MEDTRONIC PLC | $3,409,000 | +12.6% | 42,500 | +13.3% | 2.01% | +59.0% |
| ALXN | New | ALEXION PHARMACEUTICALS INCput | $3,344,000 | – | 30,000 | +100.0% | 1.98% | – |
| SIEN | New | SIENTRA INC | $2,842,000 | – | 294,172 | +100.0% | 1.68% | – |
| DXCM | New | DEXCOM INC | $2,754,000 | – | 37,140 | +100.0% | 1.63% | – |
| VRAY | Buy | VIEWRAY INC | $2,713,000 | -19.1% | 422,000 | +16.6% | 1.60% | +14.3% |
| QGEN | New | QIAGEN NV | $2,423,000 | – | 75,000 | +100.0% | 1.43% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INCput | $2,124,000 | – | 600,000 | +100.0% | 1.26% | – |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $1,975,000 | +107.7% | 50,000 | +78.7% | 1.17% | +193.2% |
| NTUS | New | NATUS MED INC DEL | $1,939,000 | – | 57,620 | +100.0% | 1.14% | – |
| AMGN | New | AMGEN INCcall | $1,705,000 | – | 10,000 | +100.0% | 1.01% | – |
| AGN | New | ALLERGAN PLCput | $1,683,000 | – | 10,000 | +100.0% | 0.99% | – |
| AGN | New | ALLERGAN PLC | $1,683,000 | – | 10,000 | +100.0% | 0.99% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INCcall | $1,609,000 | – | 100,000 | +100.0% | 0.95% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $1,504,000 | – | 100,000 | +100.0% | 0.89% | – |
| ARAY | New | ACCURAY INCcall | $1,500,000 | – | 300,000 | +100.0% | 0.89% | – |
| CSII | New | CARDIOVASCULAR SYS INC DEL | $1,469,000 | – | 67,000 | +100.0% | 0.87% | – |
| NVTRQ | New | NUVECTRA CORP | $1,465,000 | – | 112,500 | +100.0% | 0.86% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $1,340,000 | – | 71,459 | +100.0% | 0.79% | – |
| INCY | New | INCYTE CORP | $1,250,000 | – | 15,000 | +100.0% | 0.74% | – |
| GKOS | New | GLAUKOS CORP | $1,233,000 | – | 40,000 | +100.0% | 0.73% | – |
| CFMS | New | CONFORMIS INC | $1,060,000 | – | 731,041 | +100.0% | 0.63% | – |
| KALA | New | KALA PHARMACEUTICALS INC | $1,029,000 | – | 65,000 | +100.0% | 0.61% | – |
| EOLS | New | EVOLUS INC | $926,000 | – | 102,544 | +100.0% | 0.55% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $821,000 | – | 25,782 | +100.0% | 0.48% | – |
| ARRY | New | ARRAY BIOPHARMA INCcall | $816,000 | – | 50,000 | +100.0% | 0.48% | – |
| CLSD | New | CLEARSIDE BIOMEDICAL INC | $725,000 | – | 67,610 | +100.0% | 0.43% | – |
| TGTX | New | TG THERAPEUTICS INC | $710,000 | – | 50,000 | +100.0% | 0.42% | – |
| FATE | New | FATE THERAPEUTICS INC | $582,000 | – | 59,600 | +100.0% | 0.34% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $563,000 | – | 5,000 | +100.0% | 0.33% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lput | $515,000 | – | 20,000 | +100.0% | 0.30% | – |
| JNCE | New | JOUNCE THERAPEUTICS INC | $485,000 | – | 21,700 | +100.0% | 0.29% | – |
| MOTS | New | MOTUS GI HLDGS INC | $448,000 | – | 100,000 | +100.0% | 0.26% | – |
| ARAY | New | ACCURAY INC | $445,000 | – | 88,958 | +100.0% | 0.26% | – |
| KALA | New | KALA PHARMACEUTICALS INCput | $237,000 | – | 15,000 | +100.0% | 0.14% | – |
| VBLT | New | VASCULAR BIOGENICS LTDput | $230,000 | – | 100,000 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.